Company profile

Lundbeck LLC

Privately held: no public share price

Assets

(3 total)
3Total Assets
3Approved
0Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
Showing 3 of 3 assets
Target & Modality
Carbamazepine
Approved
Voltage-gated sodium channelSmall molecule
Epilepsy
Clobazam (Onfi)(Onfi)
Approved
GABA-A receptorSmall molecule
Epilepsy
Vigabatrin (Sabril)(Sabril)
Approved
GABA transaminase (GABA-T)Small molecule
Epilepsy

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.